C 
Centene CNC · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
68.54
-1.72%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$194.78bn
FY2016FY2025
Net income
−$6.67bn
FY2016FY2025
Free cash flow
$4.32bn
FY2016FY2025
Shareholders' equity
$19.95bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.78bn | $163.07bn | $154.00bn | $144.55bn | $125.98bn | $111.11bn | $74.64bn | $60.12bn | $48.38bn | $40.61bn |
| Operating income | −$7.62bn | $3.88bn | $3.65bn | $2.63bn | $2.45bn | $3.08bn | $2.19bn | $1.46bn | $1.20bn | $1.26bn |
| Net income | −$6.67bn | $3.31bn | $2.70bn | $1.20bn | $1.35bn | $1.81bn | $1.32bn | $900.0m | $828.0m | $562.0m |
| Diluted earnings per share | -13.59 | 6.58 | 5.03 | 2.15 | 2.28 | 3.12 | 3.13 | 2.14 | 2.34 | 1.60 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $77.66bn | $82.44bn | $84.64bn | $76.87bn | $78.38bn | $68.72bn | $40.99bn | $30.90bn | $21.86bn | $20.20bn |
| Cash and short-term investments | $17.89bn | $16.68bn | $19.65bn | $14.39bn | $14.66bn | $12.38bn | $12.99bn | $6.06bn | $4.60bn | $4.43bn |
| Total liabilities | $57.60bn | $55.94bn | $58.69bn | $52.63bn | $51.35bn | $42.76bn | $28.30bn | $19.88bn | $14.98bn | $14.14bn |
| Debt | $17.40bn | $18.53bn | $17.83bn | $18.02bn | $18.84bn | $16.78bn | $13.73bn | $6.69bn | $4.70bn | $4.66bn |
| Shareholders' equity | $19.95bn | $26.41bn | $25.84bn | $24.06bn | $26.80bn | $25.77bn | $12.55bn | $10.92bn | $6.85bn | $5.89bn |
| Shares outstanding | 491m | 502m | 538m | 560m | 592m | 580m | 422m | 420m | 354m | 351m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $5.09bn | $154.0m | $8.05bn | $6.26bn | $4.21bn | $5.50bn | $1.48bn | $1.23bn | $1.49bn | $1.85bn |
| Capital spending | −$767.0m | −$644.0m | −$799.0m | −$1.00bn | −$910.0m | −$869.0m | −$730.0m | −$675.0m | −$422.0m | −$306.0m |
| Free cash flow | $4.32bn | −$490.0m | $7.25bn | $5.26bn | $3.29bn | $4.63bn | $753.0m | $559.0m | $1.07bn | $1.54bn |
| Dividends paid | — | — | −$88.0m | — | −$35.0m | — | — | −$6.08bn | −$66.0m | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.38bn | $49.94bn | $49.73bn | $49.69bn | $48.74bn | $46.62bn | $40.80bn | $42.02bn |
| Operating income | $1.53bn | $2.26bn | −$1.74bn | −$6.95bn | −$458.0m | $1.70bn | $347.0m | $841.0m |
| Net income | $1.09bn | $1.54bn | −$1.10bn | −$6.63bn | −$253.0m | $1.31bn | $283.0m | $713.0m |
| Diluted earnings per share | 2.19 | 3.10 | -2.24 | -13.50 | -0.52 | 2.67 | 0.56 | 1.42 |
| Cash from operations | $4.37bn | $3.60bn | $437.0m | $1.36bn | $1.78bn | $1.51bn | −$587.0m | −$978.0m |
| Capital spending | −$174.0m | −$200.0m | −$213.0m | −$211.0m | −$208.0m | −$135.0m | −$154.0m | −$153.0m |
| Free cash flow | $4.20bn | $3.40bn | $224.0m | $1.15bn | $1.58bn | $1.38bn | −$741.0m | −$1.13bn |
| Total assets | $83.01bn | $81.17bn | $77.66bn | $82.09bn | $86.39bn | $87.04bn | $82.44bn | $82.35bn |
| Cash and short-term investments | $27.06bn | $23.74bn | $17.89bn | $19.24bn | $17.28bn | $17.29bn | $16.68bn | $17.57bn |
| Debt | $16.11bn | $16.37bn | $17.55bn | $17.58bn | $17.58bn | $18.32bn | $18.69bn | $17.61bn |
| Shareholders' equity | $22.56bn | $21.43bn | $19.95bn | $20.95bn | $27.41bn | $27.92bn | $26.41bn | $27.31bn |
Financial ratios
Data as of 27 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -3.9% | 2.4% | 2.4% | 1.8% | 1.9% | 2.8% |
| Net margin | -3.4% | 2.0% | 1.8% | 0.8% | 1.1% | 1.6% |
| Return on equity | -33.4% | 12.5% | 10.5% | 5.0% | 5.0% | 7.0% |
| Return on assets | -8.6% | 4.0% | 3.2% | 1.6% | 1.7% | 2.6% |
| Free cash flow yield | 19.3% | 2.6% | 26.6% | 21.0% | 14.0% | 17.8% |
| Revenue growth | 19.4% | 5.9% | 6.5% | 14.7% | 13.4% | 48.9% |
| Earnings growth | -301.9% | 22.3% | 124.8% | -10.8% | -25.5% | 36.9% |
| Current ratio | 1.68x | 1.11x | 1.11x | 1.06x | 1.11x | 1.08x |
| Debt to equity | 0.88x | 0.71x | 0.70x | 0.76x | 0.71x | 0.66x |
| Equity ratio | 25.7% | 32.0% | 30.5% | 31.3% | 34.2% | 37.5% |
| Interest coverage | -11.24x | 5.52x | 5.03x | 3.95x | 3.68x | 4.23x |
| Buybacks as a share of market value | 2.2% | 6.6% | 4.0% | 5.4% | -2.0% | -37.4% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 10.5% | 11.9% | 23.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -1.0% | 0.4% | 0.9% | 1.3% |
| Net margin | -0.9% | 0.1% | 0.4% | 0.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -3.0 | 5.5 | 8.8 | 22.8 | 21.6 | 11.5 | 12.0 | 16.1 | 12.8 | 10.5 |
| Price to sales | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Market value over time
31 Oct 2016 to 25 Sept 2026, in USD
$10.97bn$30.76bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 11% | -20% | -8% | -1% | 40% | -5% | 7% | 12% | 82% | -14% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 2-for-1 split · 7 Feb 2019
- 2-for-1 split · 20 Feb 2015
- 2-for-1 split · 20 Dec 2004
- 3-for-2 split · 14 Jul 2003
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.